Zecotek Photonics Inc. Announces Two New Patent Publications Covering Advanced LFS Crystal Formulations And Silicon Photo-Detectors
SINGAPORE, Oct. 22, 2014 /PRNewswire/ - Zecotek Photonics Inc. (TSX-V: ZMS; Frankfurt: W1I.F), a developer of leading-edge photonics technologies for industrial, healthcare and scientific markets, today announced today announced the recent publication by the U.S. Patent and Trademark Office (USPTO) of two new strategic patents covering more advanced variants of its flagship lutetium-based LFS scintillation crystals and solid-state MAPD photo-detector arrays. The compositions and variants of Zecotek's existing LFS crystals, are used as single elements, arrays and plates for a wide spectrum of applications.
"Our scientists have developed more advanced LFS crystal formulations to support the Integrated Detector Modules for new configurations of PET scanner designs. The modules are configured by our partner Hamamatsu," said Dr. A.F. Zerrouk, Chairman, President, and CEO of Zecotek Photonics Inc. "Our latest LFS crystal variants have tunable emission maxima for optimal coupling with our upgraded version of MAPD photo-detectors to be used in Time Of Flight PET scanners and High Energy Physics at CERN."
Dr. Zerrouk further added, "protecting our intellectual property is of utmost importance - and these two new patent filings further strengthen our IP position on these pioneering technologies and provide more advantageous, secure and cost effective alternatives for a substantial and fast growing market."
About Zecotek's LFS Crystals
Zecotek's patented Lutetium Fine Silicate (LFS) scintillation crystals
(US Patent No. 7,132,060) possess exceptional combinations of high
light yield, ultra-fast fast decay times, and enhanced radiation
hardness. As verified by independent laboratories and research centers
around the world, Zecotek's LFS crystals are by far the brightest and
fastest lutetium-based scintillation crystals on the market today,
besides being the most practical scintillation crystals for medical,
scientific and industrial imaging. Zecotek's Russian pioneering
scientists have mastered the art of altering the optical emission
centres within lutetium silicate host crystals to achieve a wide range
of desirable physical parameters tunable to specific industrial needs
and applications. All this is augmented by the ability of Zecotek to
supply the LFS crystal with guaranteed competitive cost, high quality
in a variety of dimensions and shapes, through its manufacturer BOET of
Beijing, China.
About Zecotek's MAPD Photo Detectors
Zecotek's patented solid-state Multi-pixel Avalanche Photo-Diode (MAPD)
arrays (US Patent No. 8,742,543) are advanced high-performance
solid-state photo detectors for registering various light intensities
within the wavelength range from UV to near IR. Zecotek's solid-state
MAPD is designed to replace the earlier photo-detection technologies
now used in areas such as high energy physics, astronomy, medical
diagnostics, pharmaceutical research, and other areas of industry,
security, and defense. In particular, the MAPD offers a more robust,
sensitive, and cost effective replacement for the Photo Multiplying
Tube (photomultiplier or PMT) as well as other so named SiPM's used in
PET (Positron Emission Tomography).
About Zecotek
Zecotek Photonics Inc (TSX-V: ZMS; Frankfurt: W1I) is a photonics
technology company developing high-performance scintillation crystals,
photo detectors, positron emission tomography scanning technologies, 3D
auto-stereoscopic displays, and lasers for applications in medical,
high-tech and industrial sectors. Founded in 2004, Zecotek operates
three divisions: Imaging Systems, Laser Systems and 3D Display Systems
with labs located in Canada, Korea, Russia, Singapore and U.S.A. The
management team is focused on building shareholder value by
commercializing over 50 patented and patent pending novel photonic
technologies directly and through strategic alliances and joint
ventures with leading industry partners including Hamamatsu Photonics
(Japan), the European Organization for Nuclear Research (Switzerland),
Beijing Opto-Electronics Technology Co. Ltd. (China), NuCare Medical
Systems (South Korea), the University of Washington (United States),
and National NanoFab Center (South Korea). For more information visit www.zecotek.com, follow @zecotek on Twitter and "like" us in Facebook at www.facebook.com/zecotek.
This press release may contain forward-looking statements that are based on management's expectations, estimates, projections and assumptions. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what may have been stated.
The TSX Venture 50® are the top 10 companies listed on the TSX Venture Exchange, in each of five major industry sectors - mining, oil & gas, technology & life sciences, diversified industries and clean technology - based on a ranking formula with equal weighting given to return on investment, market cap growth, trading volume and analyst coverage. All data was as of December 31, 2013.
Neither the TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the content of this news release. If you would like to receive news from Zecotek in the future please visit the corporate website at www.zecotek.com.
SOURCE Zecotek Photonics Inc.
Image with caption: "Zecotek - Leading the Way in Photonics (CNW Group/Zecotek Photonics Inc.)". Image available at: http://photos.newswire.ca/images/download/20141022_C9077_PHOTO_EN_43084.jpg
